I-125 seeds brachytherapy combined with immunotherapy for MET amplification in non-small cell lung cancer from clinical application to related lncRNA mechanism explore: a case report

I-125 seeds brachytherapy combined with immunotherapy for MET amplification in non-small cell lung cancer from clinical application to related lncRNA mechanism explore: a case report

Advanced non-small cell lung cancer (NSCLC) with MET amplification primarily relies on MET inhibitors for treatment, but once resistance occurs, the available treatment options are limited and the prognosis is typically poor. A 57-year-old man with advanced NSCLC and C-MET amplification was initiall...

Full description

Bibliographic Details
Main Authors: Mingxing Yang, Yuanli You, Xiuqing Wang, Wen Dong
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
immunotherapy
MET aberration
non-small cell lung cancer
brachytherapy
outcome
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2023.1176083/full

Internet

https://www.frontiersin.org/articles/10.3389/fcell.2023.1176083/full

Similar Items